New drug combination may combat hearing loss

Image
IANS New York
Last Updated : Feb 22 2017 | 7:04 PM IST

Researchers have discovered a drug combination that can regenerate hair cells in human ears that detect sound waves and translate them into nerve signals enabling us to hear sounds.

Each human being is born with about 15,000 hair cells per ear and once damaged, these cells cannot regrow -- one of the leading causes of hearing loss.

The findings showed that the new combination of drugs expands the population of progenitor cells -- also called supporting cells -- in the ear and induces them to become hair cells, offering a potential new way to treat hearing loss.

"Hearing loss is a real problem as people get older. It's very much of an unmet need, and this is an entirely new approach," said Robert Langer, Professor at Massachusetts Institute of Technology.

The drugs could be injected into the middle ear, from which they would diffuse across a membrane into the inner ear, the researchers said.

For the study, appearing in the journal Cell Reports, the team exposed cells from a mouse cochlea -- the spiral cavity of the inner ear containing the organ of Corti, that produces nerve impulses in response to sound vibrations -- grown in a lab dish, to molecules that stimulate the Wnt pathway, which makes the cells multiply rapidly.

Once they had a large pool of immature progenitor cells, the researchers added another set of molecules that provoked the cells to differentiate into mature hair cells, which generated about 60 times more mature hair cells than the previously used technique.

"We only need to promote the proliferation of these supporting cells, and then the natural signalling cascade that exists in the body will drive a portion of those cells to become hair cells," said Jeffrey Karp, Associate Professor at Brigham and Women's Hospital (BWH) in Boston.

--IANS

rt/lok/dg

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 22 2017 | 6:54 PM IST

Next Story